About this trial
This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.
Eligibility criteria
Qualifiers
Females aged 30-60 years.
BMI 18.5-40 kg/m².
Recreationally active (≥30 min/wk moderate intensity exercise).
Healthy and free from disease per health history questionnaire.
Disqualifiers
Currently supplementing whey protein.
Pregnant or nursing.
Lactose intolerant.
Currently using creatine monohydrate.
Trial design
Treatments tested in this trial
- Triple protein support
- Placebo
Treatment groups
Sponsors and collaborators
University of North Carolina, Chapel Hill
Lead sponsor
Perelel Inc.
Collaborator